HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Worel Selected Research

Paclitaxel (Taxol)

3/2016Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party.
5/2001Kinetics of PBPC mobilization by cyclophosphamide, as compared with that by epirubicin/paclitaxel followed by G-CSF support: implications for optimal timing of PBPC harvest.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Worel Research Topics

Disease

5Multiple Myeloma
07/2014 - 06/2001
4Hemolysis
01/2014 - 11/2003
2Lymphoma (Lymphomas)
07/2014 - 03/2011
2Leukemia
03/2001 - 01/2001
1Communicable Diseases (Infectious Diseases)
12/2023
1COVID-19
12/2023
1Neoplasms (Cancer)
03/2016
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
03/2016
1Hodgkin Disease (Hodgkin's Disease)
08/2012
1Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2012
1Bronchiolitis Obliterans Syndrome
04/2012
1Immunoglobulin Light-chain Amyloidosis
01/2012
1Renal Insufficiency (Renal Failure)
01/2012
1Paraproteinemias (Monoclonal Gammopathy)
09/2009
1B-Cell Lymphoma (Lymphoma, B Cell)
09/2009
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2008
1Graft vs Host Disease (Graft-Versus-Host Disease)
11/2003
1Hematologic Neoplasms (Hematological Malignancy)
11/2003
1Pathologic Complete Response
11/2002
1Breast Neoplasms (Breast Cancer)
05/2001
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2001
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2000

Drug/Important Bio-Agent (IBA)

3plerixaforFDA Link
08/2012 - 03/2011
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
03/2011 - 01/2001
2Paclitaxel (Taxol)FDA LinkGeneric
03/2016 - 05/2001
2Hemoglobins (Hemoglobin)IBA
01/2014 - 12/2013
2PotassiumIBA
01/2014 - 12/2013
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
12/2013
1Adenosine Triphosphate (ATP)IBA
04/2010
1Adenosine Monophosphate (AMP)IBA
04/2010
1Adenosine Diphosphate (ADP)IBA
04/2010
1Immunoglobulin M (IgM)IBA
09/2009
1ParaproteinsIBA
09/2009
1Hemagglutinins (Hemagglutinin)IBA
11/2003
1HLA Antigens (Human Leukocyte Antigens)IBA
11/2003
1Blood Group Antigens (Blood Groups)IBA
11/2003
1Epirubicin (Ellence)FDA LinkGeneric
05/2001
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2001

Therapy/Procedure

7Drug Therapy (Chemotherapy)
03/2016 - 01/2001
5Stem Cell Transplantation
12/2023 - 03/2001
4Therapeutics
12/2023 - 06/2001
2Transplantation
03/2016 - 07/2014
2Autologous Transplantation
03/2011 - 01/2001
1Cell Transplantation
12/2023
1Salvage Therapy
03/2016
1Induction Chemotherapy
03/2016
1Blood Transfusion (Blood Transfusions)
12/2013
1Catheters
12/2013
1Hematopoietic Stem Cell Mobilization
08/2012
1Hematopoietic Stem Cell Transplantation
04/2012
1Immunotherapy
03/2001
1Blood Component Removal (Apheresis)
01/2001
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2000